Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: emil who wrote (2110)	7/22/1998 8:12:00 PM
From: emil	Respond to of 4676

NEW YORK, July 22 (Reuters) - Shares of Isis Pharmaceuticals (ISIP - news) rose sharply in after-hours trade Wednesday after news that a U.S. advisory panel had backed the company's drug, Vitravene, which is used for a retinal blindness that affects AIDS patients. Isis traded at 17-1/2 on the Instinet system. The stock, which was halted Wednesday for pending news, closed Tuesday at 13-7/16. ....Joe Kernen reported afterhours of 17 7/8... Hate to be a short tomorrow. Covering by the former naysayers will magnify whatever move up that this stock has, since it the short position is substantial. I think 20's are not unrealistic in the afternoon.